International Graphite (ASX: IG6) strikes European graphite processing JV with Italian chemical group ALKEEMIA at Porto Marghera
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
The Las Vegas Strip just got a pricing experiment, and MGM Resorts International is betting guests will notice
Read More 5 minute read Pharma Industry News Ipsen secures global licensing option for Origami’s selective protein degrader platform Ipsen has signed a global option deal with Origami Therapeutics for a rare CNS protein degrader. Find out what this signals for neuro drug strategy. byPallavi MadhirajuFebruary 2, 2026